Skip to main content

The mutational status of the p53 tumor suppressor gene is a determinant of GSTP1 expression and mediates GSTP1-dependent drug resistance in human glioblastoma

Publication ,  Conference
Antoun, GR; McLendon, R; Friedman, H; Friedman, A; Bigner, D; Ali-Osman, F
Published in: CANCER RESEARCH
2012

Duke Scholars

Published In

CANCER RESEARCH

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2012

Volume

72

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Antoun, G. R., McLendon, R., Friedman, H., Friedman, A., Bigner, D., & Ali-Osman, F. (2012). The mutational status of the p53 tumor suppressor gene is a determinant of GSTP1 expression and mediates GSTP1-dependent drug resistance in human glioblastoma. In CANCER RESEARCH (Vol. 72). https://doi.org/10.1158/1538-7445.AM2012-1177
Antoun, Gamil R., R. McLendon, H. Friedman, A. Friedman, D. Bigner, and F. Ali-Osman. “The mutational status of the p53 tumor suppressor gene is a determinant of GSTP1 expression and mediates GSTP1-dependent drug resistance in human glioblastoma.” In CANCER RESEARCH, Vol. 72, 2012. https://doi.org/10.1158/1538-7445.AM2012-1177.
Antoun, Gamil R., et al. “The mutational status of the p53 tumor suppressor gene is a determinant of GSTP1 expression and mediates GSTP1-dependent drug resistance in human glioblastoma.” CANCER RESEARCH, vol. 72, 2012. Wos-lite, doi:10.1158/1538-7445.AM2012-1177.

Published In

CANCER RESEARCH

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2012

Volume

72

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis